Gene · 3822
KLRC2: killer cell lectin like receptor C2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. KLRC2: killer cell lectin like receptor C2. Genes, record 3822. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3822
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P26717 | NKG2-C type II integral membrane protein | 231 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents16
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 50762 | P26717 | Espacenet |
| JP 2025540077 A | 2025-12-11 | 1 | P26717 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 10842 | P26717 | Espacenet |
| EP 4626925 A1 | 2025-10-08 | 1 | P26717 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 10842 | P26717 | Espacenet |
| US 12030936 B2 | 2024-07-09 | 38 | P26717 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 44108 | P26717 | Espacenet |
| JP 2022530677 A | 2022-06-30 | 42 | P26717 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 147079 | P26717 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 5985 | P26717 | Espacenet |
1 to 10 of 16
See all 16 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,297
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | KLRC2 papers | Newest fiscal year |
|---|---|---|---|
| P01CA065493 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies | 45 | 2025 |
| P01CA111412 | NK cells, their receptors and cancer therapy | 45 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 24 | 2025 |
| P30CA077598 | Cancer Center Support Grant | 20 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 18 | 2025 |
| R01AI100874 | The natural killer cell response against mouse cytomegalovirus infection | 14 | 2025 |
| T32AI007290 | Molecular and Cellular Immunobiology | 13 | 2025 |
| P30AI060354 | Harvard University Center for AIDS Research | 10 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 10 | 2025 |
| P30DK026743 | UCSF Liver Center | 10 | 2025 |
1 to 10 of 1,297Source NIH's project files
See all 1,297 nih grantsPapers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impaired control of autoimmunity increases pediatric multiple sclerosis risk in EBNA-1-seropositives and -seronegatives. | Proc Natl Acad Sci U S A | 2026 | 42821346 | PubTator, text mining | PubMed |
| Natural Killer Cells in Kidney Transplantation: Dual Role in Allograft Injury and Immune Adaptation. | Arch Immunol Ther Exp (Warsz) | 2026 | 42814514 | PubTator, text mining | PubMed |
| The Impact of Aerobic Exercise on Circulating T-Cells and NK-Cells in Colorectal Cancer Survivors: A Secondary Analysis of a Randomized Trial. | Cancer Control | 2026 | 42808444 | PubTator, text mining | PubMed |
| NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma. | J Immunother Cancer | 2026 | 42767769 | PubTator, text mining | PubMed |
| Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. | Cancers (Basel) | 2026 | 42738255 | PubTator, text mining | PubMed |
| Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy. | Nat Immunol | 2026 | 42680897 | PubTator, text mining | PubMed |
| Gravidity-dependent protection against placental malaria is associated with enhanced natural killer cell-mediated antibody-dependent cellular activation: a nested cohort study. | EBioMedicine | 2026 | 42660020 | PubTator, text mining | PubMed |
| The Natural Killer Cell Landscape in the Natural History of Hantavirus Cardiopulmonary Syndrome in a Chilean Cohort. | Viruses | 2026 | 42515563 | PubTator, text mining | PubMed |
| Tumor-derived ITGB3 shapes a primed but functionally constrained NK cell state in breast cancer through HLA-E-NKG2A signaling. | Mol Biol Rep | 2026 | 42507293 | PubTator, text mining | PubMed |
| Qibai Pingfei Capsule ameliorates NK‑cell dysfunction in COPD: Insights from single‑cell sequencing in a randomized multicenter double‑blinded placebo‑controlled trial. | Phytomedicine | 2026 | 42475870 | PubTator, text mining | PubMed |
1 to 10 of 2,624
See all 2,624 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3822
GET https://conductscience.org/api/genes/v1/3822/patents